Vicore Pharma Holding AB
556680-3804ActiveDeveloping novel ATRAG drugs for severe respiratory diseases.
Oversigt
- 5–9
- Medarbejdere
- 100–500mio SEK
- Omsætning
- 2005
- Grundlagt
Beskrivelse
Vicore is an innovative, clinical-stage pharmaceutical company focused on developing life-changing treatments for severe diseases where the AT2 receptor plays a central role. Their primary ambition is unlocking the potential of Angiotensin II Type 2 Receptor Agonists (ATRAGs), a new class of drugs w...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Verksamheter som utövas av huvudkontor
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556680380401
Beslutningstagere
Ingen beslutningstagere fundet endnu
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
CALLUNA PHARMA AS
10 medarbejdereClinical stage biotech pioneering antibodies for inflammation and fibrosis.
Melius Pharma AB
0 medarbejdereSwedish clinical-stage pharma developing low-risk IPF cough treatment.
DiaBridge AB
0 medarbejdereDeveloping breakthrough drugs targeting DNA repair for cancer and inflammation.
Cereno Scientific AB
10–19 medarbejderePioneering disease-modifying treatments for rare cardiovascular and pulmonary diseases.
Cinclus Pharma Holding AB (publ)
20–49 medarbejdereSwedish clinical-stage pharma developing superior GERD treatment drug candidate.
Udforsk mere
Spørgsmål om Vicore Pharma Holding AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo